ESR1 and breast carcinoma: Possible mechanism of actions in inhibiting breast cancer could be: inducing PPARγ expression and as a result reducing the expression of ERα, inducing Nrf2 which consequently reduces inflammation and oxidative stress, and inhibiting cell proliferation while inducing apoptosis.